Related Experiment Video
Updated: Jul 12, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
External Validation and Head-to-Head Comparison of Cuore and Score2 Cardiovascular Risk Scores in an Italian Primary
Alberto Milanese1, Antonio Giampiero Russo1
1Epidemiology Unit, Health Protection Agency (ATS) of Milan.
Aims:
To externally validate and compare CUORE and SCORE2 for 10-year prediction of first fatal or non-fatal myocardial infarction or stroke in an Italian primary care cohort, and to quantify the impact of administrative endpoint definition and model recalibration.
Methods And Results:
We studied 38,101 adults in ATS Milan (baseline 2007-2009) with primary care risk factors linked to hospital discharge and mortality registries for 10-year follow-up. The endpoint was first fatal or non-fatal myocardial infarction or stroke, ascertained using a strict (primary diagnosis/procedure fields) and a broad (any diagnosis/procedure field) administrative definition. Discrimination was assessed with IPCW time-dependent AUC and calibration with decile plots, calibration-in-the-large and calibration slope, comparing uncalibrated and recalibrated implementations. SCORE2 AUC ranged 0.713-0.720, whereas CUORE ranged 0.730-0.741. Broad ascertainment increased event rates (SCORE2: 5.6% vs 4.4%; CUORE: 6.8% vs 5.0%) without materially changing AUC. SCORE2 showed more stable calibration, whereas CUORE showed calibration slopes <1.
Conclusion:
In this real-world Italian cohort, CUORE and SCORE2 provided robust ordinal risk stratification and moderate discrimination at 10 years. Absolute risk estimates were sensitive to administrative endpoint mapping and recalibration strategy, supporting transparent endpoint reporting and local calibration assessment before applying risk thresholds in practice.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Assessment of blood pressure in brachial artery(two-step method)
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Relative Risk